From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!BLUE.WEEG.UIOWA.EDU!twiese
From: twiese@BLUE.WEEG.UIOWA.EDU ("T. Wiese")
Newsgroups: bionet.diagnostics
Subject: Source of bulk carbohydrates
Date: 1 Aug 1995 18:59:03 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 6
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.A32.3.91.950801205024.39871A-100000@red.weeg.uiowa.edu>
NNTP-Posting-Host: net.bio.net

Dear Colleagues,
	Does anyone know of sources of bulk quantities of carbohydrates 
(kg amounts) other than Pfanstiel?  Does Waco (sp?) of Japan isolate 
carbohydrates in bulk?
Thank you in advance,
Thomas Wiese

From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!MAIL.FWS.GOV!Mail-9DE~SMTP
From: Mail-9DE~SMTP@MAIL.FWS.GOV
Newsgroups: bionet.diagnostics
Subject: plant viruses
Date: 2 Aug 1995 08:47:50 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 55
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9507028073.AA807369263@mail.fws.gov>
NNTP-Posting-Host: net.bio.net


User coler is not defined

 Original text follows 
 ----------------------------------------------
Received: from net.bio.net by mail.fws.gov (SMTPLINK V2.10.03)
X-Envelope-From: BIOSCI-REQUEST@net.bio.net
Received: (from daemon@localhost) by net.bio.net (8.6.12/8.6.6) id
EAA29333 for diagnost-list; Wed, 2 Aug 1995 04:32:50 -0700
Received: (from news@localhost) by net.bio.net (8.6.12/8.6.6) id
EAA29329 for diagnost-arpanet; Wed, 2 Aug 1995 04:32:49 -0700
To: diagnost@net.bio.net
From: burns@sasa.gov.uk (Robert Burns)
Subject: Potato Virus V
Date: 2 Aug 1995 04:32:44 -0700
Sender: daemon@net.bio.net
Message-ID:
<MAPI.Id.0016.0075726e732020203634314530303031@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

Hi, any plant virologists out there?  We are looking for isolates
of PVV for evaluation of some Mabs that we have, can anyone help?
We are particularly interested in sources outside of UK/Europe


Robert



Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk






Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!MAIL.FWS.GOV!Mail-9DE~SMTP
From: Mail-9DE~SMTP@MAIL.FWS.GOV
Newsgroups: bionet.diagnostics
Subject: conjugate stability
Date: 2 Aug 1995 08:44:26 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 66
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9507028073.AA807368724@mail.fws.gov>
NNTP-Posting-Host: net.bio.net


User coler is not defined

Received: from net.bio.net by mail.fws.gov (SMTPLINK V2.10.03)
X-Envelope-From: BIOSCI-REQUEST@net.bio.net
Received: (from daemon@localhost) by net.bio.net (8.6.12/8.6.6) id
EAA29200 for diagnost-list; Wed, 2 Aug 1995 04:29:59 -0700
Received: (from news@localhost) by net.bio.net (8.6.12/8.6.6) id
EAA29192 for diagnost-arpanet; Wed, 2 Aug 1995 04:29:56 -0700
To: diagnost@net.bio.net
From: burns@sasa.gov.uk (Robert Burns)
Subject: storage of conjugates
Date: 2 Aug 1995 04:29:45 -0700
Sender: daemon@net.bio.net
Message-ID:
<MAPI.Id.0016.0075726e732020203632353330303030@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

We routinely make monoclonal AP conjugates by thiolation of the
antibody followed by reaction with activated AP. We find that thge
storage conditions for each conjugate is dependent on the Mab used.

Some conjugates store well at 4C, some don't. All of them store well
at -20C. We have also been looking at a Pierce product called 
superfreeze which allows liquid storage of conjugates at -20C which
should increase longevity. We find that some conjugates store better
with it and some without. BTW in some cases conjugates stored with
superfreeze had decreased activity compared to aliquots of the same
batch stored at 4C without it!

I think with Mab conjugates it all depends on the parent antibody.


Anybody else got any conjugate stories?


Robert



Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk






Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!sasa.gov.uk!burns
From: burns@sasa.gov.uk (Robert Burns)
Newsgroups: bionet.diagnostics
Subject: test ignore
Date: 2 Aug 1995 08:40:20 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 12
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.0075726e732020203945413830303031@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net


Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!sasa.gov.uk!burns
From: burns@sasa.gov.uk (Robert Burns)
Newsgroups: bionet.diagnostics
Subject: Potato Virus V
Date: 2 Aug 1995 04:32:44 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 20
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.0075726e732020203634314530303031@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

Hi, any plant virologists out there?  We are looking for isolates
of PVV for evaluation of some Mabs that we have, can anyone help?
We are particularly interested in sources outside of UK/Europe


Robert



Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!sasa.gov.uk!burns
From: burns@sasa.gov.uk (Robert Burns)
Newsgroups: bionet.diagnostics
Subject: storage of conjugates
Date: 2 Aug 1995 04:29:45 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 33
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.0075726e732020203632353330303030@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

We routinely make monoclonal AP conjugates by thiolation of the
antibody followed by reaction with activated AP. We find that thge
storage conditions for each conjugate is dependent on the Mab used.

Some conjugates store well at 4C, some don't. All of them store well
at -20C. We have also been looking at a Pierce product called 
superfreeze which allows liquid storage of conjugates at -20C which
should increase longevity. We find that some conjugates store better
with it and some without. BTW in some cases conjugates stored with
superfreeze had decreased activity compared to aliquots of the same
batch stored at 4C without it!

I think with Mab conjugates it all depends on the parent antibody.


Anybody else got any conjugate stories?


Robert



Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!howland.reston.ans.net!news.sprintlink.net!uunet!in1.uu.net!uunet.ca!news.uunet.ca!inforamp.net!usenet
From: rleavitt@on.novamann.ca (Randy Leavitt)
Newsgroups: bionet.diagnostics
Subject: Re: Single substrate component for TMB
Date: Tue, 01 Aug 95 13:10:25 PST
Organization: GfWare
Lines: 24
Distribution: world
Message-ID: <3vlmsj$97@inforamp.net>
References: <199507161426.WAA27105@einstein.technet.sg>
NNTP-Posting-Host: ts2-02.inforamp.net
Mime-Version: 1.0
X-Newsreader: WinVN 0.93.6

In article <199507161426.WAA27105@einstein.technet.sg>, pohyam@TECHNET.SG 
says...
>
>I have always been using the two component OPD and BCIP/NBT coupled with 
HRP 
>for my ELISA assays. Recently, I read that a new single component TMB 
>substrate for HRP is on sale. Has anyone tried this? Is it superior in 
terms 
>of OD duplicity and stability of colour development? Can someone share 
their 
>experience with me?
>
>
>

We have used the single component TMB substrate for the past 2 years in 
our single step ELISAs for drugs in the race horse.  Use of the product 
(K-Blue) has improved sensitivities, precision and made for easier 
handling than the classical 2 component system.

K-Blue is available from ELISA TECHNOLOGIES in Lexington, KY 
(606-266-9556).



From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Newsgroups: bionet.diagnostics
Path: biosci!bcm!cs.utexas.edu!swrinde!tank.news.pipex.net!pipex!news.sprintlink.net!crash!kiehl
From: b3748@cts.com (Bryan Kiehl)
Subject: Re: Storage of conjugates
Organization: CTSNET
Date: Wed, 2 Aug 1995 01:34:03 GMT
Message-ID: <3vmkmb$1s4k_001@kiehl.cts.com>
X-Newsreader: News Xpress Version 1.0 Beta #3
References: <199508010812.BAA11589@net.bio.net>
Sender: news@crash.cts.com (news subsystem)
Nntp-Posting-Host: kiehl.cts.com
Lines: 19

In article <199508010812.BAA11589@net.bio.net>,
   vigfrid.ness@veths.no (Vigfrid Ness) wrote:
>Hi
>Can anybody tell me the best way to store conjugated antibodies????
>
>Viffi Ness
>DYNAL AS
>
Conjugates (alkaline phosphatase or peroxidase), assuming they were prepared 
properly, can be stored at refrigeration temperatures for many months and are 
stable frozen for years. In most cases, the reason for eventual inactivity is 
microbial contamination.

Bryan Kiehl
GenBio
15222-A Avenue of Science
San Diego, CA 92128
(619) 592-9300, ext 309
(619) 592-9400 [FAX]

From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!agresearch.cri.nz!HartA
From: HartA@agresearch.cri.nz
Newsgroups: bionet.diagnostics
Subject: Nitric oxide
Date: 1 Aug 1995 22:08:27 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 8
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01HTLSLPMQJQ002DY7@INVERMAY.CRI.NZ>
NNTP-Posting-Host: net.bio.net


Dear Newsgroup members,
                                                        Does anyone have 
details on a reliable method for measuring atmospheric nitric oxide (NO).
Cheers,
               Alan Hart

                

From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!biosci!not-for-mail
From: Simon Eaton <S.J.Eaton@ncl.ac.uk>
Newsgroups: bionet.diagnostics,bionet.metabolic-reg,bionet.announce,bionet.general,sci.med
Subject: 2nd Shire Workshop: Screening for Inborn Errors of Metabolism
Date: 2 Aug 1995 10:38:42 -0700
Organization: Newcastle University, UK
Lines: 39
Sender: biohelp@net.bio.net
Approved: bionews-moderator@net.bio.net
Distribution: world
Message-ID: <3vns2c$atp@whitbeck.ncl.ac.uk>
NNTP-Posting-Host: net.bio.net
Xref: biosci bionet.diagnostics:234 bionet.metabolic-reg:513 bionet.announce:2359 bionet.general:16384 sci.med:87476

2nd SHIRE WORKSHOP
"Screening for Inborn Errors of Metabolism"
Current Status and Future Developments

25th September 1995
Lecture Theatre
The Sir James Spence Institute of Child Health
The Royal Victoria Infirmary
Newcastle upon Tyne  NE1 4LP

PROGRAMME

2.00 - 2.10pm Introduction and welcome Professor A W Craft

2.10 - 2.40pm Diagnosis of lysosomal storage disorders   Dr GTN Besley,	      
       	Willink Biochemical Genetics Unit,
        Royal Manchester Children's Hospital

2.40 - 3.20pm Neonatal Screening - what do we screen for and why?
       Dr RJ Pollit
       Neonatal Screening Laboratory
       The Children's Hospital, Sheffield
						
3.20 - 3.40pm		Tea/Coffee

3.40 - 4.20pm Neonatal Screening - how well do we screen?
       Dr A Galloway
       Neonatal Screening Laboratory, 					 
       Dryburn Hospital

4.20 - 5.00pm Neonatal Screening - what could we screen for and how?
       Professor K Bartlett
       Department of Child Health

___________________________________________________________________________

Enquiries to: Kim.Bartlett@ncl.ac.uk or Anne.Kennedy@ncl.ac.uk

___________________________________________________________________________

From owner-diagnostics@net.bio.net Tue Aug 01 23:00:00 1995
Path: biosci!sasa.gov.uk!burns
From: burns@sasa.gov.uk (Robert Burns)
Newsgroups: bionet.diagnostics
Subject: plant viruses (additional)
Date: 2 Aug 1995 09:52:51 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 21
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.0075726e732020204146364430303037@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

Whoops, should have defined PVV in my previous post. It is
Potato Virus V


Thanks


Robert


Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Wed Aug 02 23:00:00 1995
Path: biosci!MAIL.FWS.GOV!Mail-9DE~SMTP
From: Mail-9DE~SMTP@MAIL.FWS.GOV
Newsgroups: bionet.diagnostics
Subject: plant viruses (additional)
Date: 3 Aug 1995 02:52:54 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 55
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9507028073.AA807388860@mail.fws.gov>
NNTP-Posting-Host: net.bio.net



 ----------------------------------------------
Received: from net.bio.net by mail.fws.gov (SMTPLINK V2.10.03)
X-Envelope-From: BIOSCI-REQUEST@net.bio.net
Received: (from daemon@localhost) by net.bio.net (8.6.12/8.6.6) id
JAA14977 for diagnost-list; Wed, 2 Aug 1995 09:53:02 -0700
Received: (from news@localhost) by net.bio.net (8.6.12/8.6.6) id
JAA14968 for diagnost-arpanet; Wed, 2 Aug 1995 09:52:59 -0700
To: diagnost@net.bio.net
From: burns@sasa.gov.uk (Robert Burns)
Subject: plant viruses (additional)
Date: 2 Aug 1995 09:52:51 -0700
Sender: daemon@net.bio.net
Message-ID:
<MAPI.Id.0016.0075726e732020204146364430303037@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

Whoops, should have defined PVV in my previous post. It is
Potato Virus V


Thanks


Robert


Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk




=01=01=01=01


Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Thu Aug 03 23:00:00 1995
Newsgroups: bionet.diagnostics
Path: biosci!bcm!cs.utexas.edu!news.sprintlink.net!crash!kiehl
From: b3748@cts.com (Bryan Kiehl)
Subject: Re: conjugate stability
Organization: CTSNET
Date: Thu, 3 Aug 1995 22:29:06 GMT
Message-ID: <3vriji$1s88_001@kiehl.cts.com>
X-Newsreader: News Xpress Version 1.0 Beta #3
References: <9507028073.AA807368724@mail.fws.gov>
Sender: news@crash.cts.com (news subsystem)
Nntp-Posting-Host: kiehl.cts.com
Lines: 34

>
>We routinely make monoclonal AP conjugates by thiolation of the
>antibody followed by reaction with activated AP. We find that thge
>storage conditions for each conjugate is dependent on the Mab used.
>
>Some conjugates store well at 4C, some don't. All of them store well
>at -20C. We have also been looking at a Pierce product called 
>superfreeze which allows liquid storage of conjugates at -20C which
>should increase longevity. We find that some conjugates store better
>with it and some without. BTW in some cases conjugates stored with
>superfreeze had decreased activity compared to aliquots of the same
>batch stored at 4C without it!
>
>I think with Mab conjugates it all depends on the parent antibody.
>
>
>Anybody else got any conjugate stories?
>
I would agree with the above. Polyclonals have been consistent in my 
experience and can typically be stored in the refrigerator for extended 
periods if well preserved and start out sterile. Mabs are sometimes a 
different story. In fact I found that one Mab, a IgG3, usually precipitated 
out on repeated freeze thaw and was also unstable in the refrigerator.

My preservative of choice is sodium azide for alkaline phosphatase conjugates 
or any reagent if the azide doesn't interfer. You can't use azide with 
peroxidase conjugates and I recommend using ProClin.

Bryan Kiehl
GenBio
15222-A Avenue of Science
San Diego, CA 92128
(619) 592-9300, ext 309
(619) 592-9400 [FAX]

From owner-diagnostics@net.bio.net Fri Aug 04 23:00:00 1995
Path: biosci!agate!news.duke.edu!solaris.cc.vt.edu!news.bluesky.net!news.sprintlink.net!newsfeed.internetmci.com!uunet!in1.uu.net!newstf01.news.aol.com!newsbf02.news.aol.com!not-for-mail
From: nadagen@aol.com (Nadagen)
Newsgroups: bionet.diagnostics
Subject: Re: Problems with DNA based technology
Date: 5 Aug 1995 18:04:46 -0400
Organization: America Online, Inc. (1-800-827-6364)
Lines: 4
Sender: root@newsbf02.news.aol.com
Message-ID: <400ptu$r1b@newsbf02.news.aol.com>
References: <3vido4$hnf@mserv1.dl.ac.uk>
Reply-To: nadagen@aol.com (Nadagen)
NNTP-Posting-Host: newsbf02.mail.aol.com

My laboratory has had a slight problem with the logistics of running PCR
because of the ribonuclease destroying the m-RNA before the appropriate
info can be gathered....do you know how to stabilize this or have any
suggestions

From owner-diagnostics@net.bio.net Sat Aug 05 23:00:00 1995
Path: biosci!SIAL.COM!douglasm
From: douglasm@SIAL.COM (Michael Douglas)
Newsgroups: bionet.diagnostics
Subject: Re: Problems with DNA based technology
Date: 6 Aug 1995 13:25:40 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 18
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.BSI.3.91.950806151055.18883A-100000@mailgate.sial.com>
References: <400ptu$r1b@newsbf02.news.aol.com>
NNTP-Posting-Host: net.bio.net

It is essential with these sensitive methodologies that everything 
including glassware, plasticware and reagents be RNAse free.  Treat all 
reagents and solutions with DEPC (diethylpyrocarbonate), wear gloves use 
good laboratory practice as if sterile and pray.  MGD

___________________________________________________________________________
Michael Douglas					   	  douglasm@sial.com
Sigma Diagnostics    --    545 South Ewing    --    St. Louis, MO 63103 USA
FAX: 314-531-2586 or 800-816-1603  Tele: 800-521-8956 or 314-771-5765 x4435

On 5 Aug 1995, Nadagen wrote:

> My laboratory has had a slight problem with the logistics of running PCR
> because of the ribonuclease destroying the m-RNA before the appropriate
> info can be gathered....do you know how to stabilize this or have any
> suggestions
> 
> 

From owner-diagnostics@net.bio.net Mon Aug 07 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!nac.no!Norway.EU.net!EU.net!newsfeed.internetmci.com!gatech!howland.reston.ans.net!ix.netcom.com!netnews
From: t-bone13@ix.netcom.com (Dan Tisone )
Newsgroups: bionet.diagnostics
Subject: Production Equipment for Rapid Test Kits
Date: 8 Aug 1995 15:29:34 GMT
Organization: Netcom
Lines: 17
Message-ID: <407vsu$kfd@ixnews3.ix.netcom.com>
NNTP-Posting-Host: ix-ir16-13.ix.netcom.com

Our company's product line includes electric cutters, clamshell and
reel-to-reel laminators, strip and reel-to-reel X/Y
positioning/dispensing tables, and various dispensers ranging from
aerosol, to solenoid, to inkjet.  These products can be used in the R&D
process as well as in a full time manufacturing enviornment.  We also
provide consulting services on how to develop rapid diagnostics,
immunoassays, and dry chemistries.  If we can provide any assistance,
please contact me through my internet address and I can send more
information.

Daniel M. Tisone
t-bone13@ix.netcom.com

BioDot, Inc
Irvine, CA
USA


From owner-diagnostics@net.bio.net Mon Aug 07 23:00:00 1995
Path: biosci!bcm!news.msfc.nasa.gov!newsfeed.internetmci.com!news.sprintlink.net!howland.reston.ans.net!swrinde!tank.news.pipex.net!pipex!oleane!jussieu.fr!univ-lyon1.fr!swidir.switch.ch!scsing.switch.ch!news.belwue.de!news.dfn.de!uni-muenster.de!news
From: Torsten Boerchers <borcher@uni-muenster.de>
Newsgroups: bionet.diagnostics
Subject: Re: Storage of conjugates
Date: 8 Aug 1995 17:46:38 GMT
Organization: ICB
Lines: 39
Message-ID: <4087tu$16kk@majestix.uni-muenster.de>
References: <199508010812.BAA11589@net.bio.net> <3vmkmb$1s4k_001@kiehl.cts.com>
NNTP-Posting-Host: arnheim.uni-muenster.de
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Windows; I; 16bit)

b3748@cts.com (Bryan Kiehl) wrote:
>In article <199508010812.BAA11589@net.bio.net>,
>   vigfrid.ness@veths.no (Vigfrid Ness) wrote:
>>Hi
>>Can anybody tell me the best way to store conjugated antibodies????
>>
>>Viffi Ness
>>DYNAL AS
>>
>Conjugates (alkaline phosphatase or peroxidase), assuming they were prepared 
>properly, can be stored at refrigeration temperatures for many months and are 
>stable frozen for years. In most cases, the reason for eventual inactivity is 
>microbial contamination.
>
>Bryan Kiehl
>GenBio
>15222-A Avenue of Science
>San Diego, CA 92128
>(619) 592-9300, ext 309
>(619) 592-9400 [FAX]

IMHO storage conditions cannot be generalized. They
may as well depend on the antibody, the stoichiometry of
conjugation and the method of coupling.

But remember, do not use sodium azide when storing peroxidase
conjugates!! A good alternative in this case is Thimerosal.

Torsten
-------------------------------------------------------------------------/
                           Torsten Boerchers                            /
    _/  _/_/_/ _/_/_/     Institute of Chemical- and Biochemical Sensor/
   _/  _/     _/   _/    Research (Molecular Biology Group)           /
  _/  _/     _/_/_/     Mendelstr 7, D-48149 Muenster, Germany       /
 _/  _/     _/    _/   Fax: +49-251-980 2890 Phone: +49-251-980 2876/
_/  _/_/_/ _/_/_/_/   E-Mail: borcher@uni-muenster.de              /
------------------------------------------------------------------/



From owner-diagnostics@net.bio.net Mon Aug 07 23:00:00 1995
Path: biosci!sasa.gov.uk!odonnell
From: odonnell@sasa.gov.uk ("Kevin O'Donnell")
Newsgroups: bionet.diagnostics
Subject: Re: Production Equipment for Rapid Test Kits
Date: 8 Aug 1995 09:25:51 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 97
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.00646f6e6e656c6c3845453230303038@MAPI.to.RFC822>
References: <407vsu$kfd@ixnews3.ix.netcom.com>
NNTP-Posting-Host: net.bio.net

> 
> Our company's product line includes [snip] These products can be used =
in the R&D
> process as well as in a full time manufacturing enviornment. 

. Commercial postings of this kind are not allowed on bionet. See the =
extract below from the FAQ. If you wish to advertise your products on =
the net, I suggest that you either buy some web space or subscribe to =
something like biz-biotech.:

>  WHAT ARE THE RESTRICTIONS ON COMMERCIAL ACTIVITIES IN THE BIOSCI/BIONE=
T
>  NEWSGROUPS?
>
>BIOSCI is funded in part by the National Science Foundation (NSF)
>which supports the Internet in the U.S. with U.S. taxpayer dollars.
>NSF is responsible for setting Acceptable Use Policy (AUP) for the the
>NSFNet backbone section of the Internet of which BIOSCI makes
>extensive use. Because of these reasons, BIOSCI users should adhere to
>the following guidelines.
>
>Commercial activities on BIOSCI are in general prohibited except as
>noted below. People at for-profit organizations are free to read all
>postings made to the BIOSCI/bionet newsgroups, but must ensure that
>their postings to the newsgroups do not violate our guidelines.
>
>Commercial organizations may post job openings on
>EMPLOYMENT/bionet.jobs subject to the format restrictions for that
>group. Commercial job posting format restrictions for the
>EMPLOYMENT/bionet.jobs newsgroup are described above under the
>question "Where should I post my messages?" Users who violate these
>format restrictions consciously risk losing their network access.
>
>BIOSCI readers without any financial connections to a company or a
>product may discuss and/or post endorsements of a commercial product.
>However, it is standard Internet practice to include in the posting a
>disclaimer of any financial interest in the product/company. Note that
>postings to newsgroups are subject to libel laws. BIOSCI advises
>readers to think twice before taking potshots at products that they do
>not like.
>
>BIOSCI users often post general questions about problems that might be
>solved through the use of a commercial product. It is EXTREMELY
>IMPORTANT, however, that such general questions *not* be answered by
>people affiliated with the product or company that might stand to gain
>a sale as a result. For example, user X may ask, "Is there a product
>that will allow me to separate protein A from protein B given the
>following properties ...?", but, if user Y works at company Z which
>sells a product that can accomplish this task, user Y does *NOT* have
>permission to respond to the question. Responses can only be posted by
>other scientists who might have experience in solving the problem in
>question and who do not stand to gain financially by promoting the
>product in question, i.e., they are not employees, consultants, or
>connected to the company via other financial ties. As noted above,
>postings endorsing commercial products should contain a customary
>disclaimer stating the absence of financial ties of the poster to the
>product/company.
>
>Commercial companies MAY RESPOND to a public BIOSCI newsgroup if a
>BIOSCI user asks a question directly about one of their products,
>e.g., mentions it by name. The response should be limited to a factual
>answer of the question posed and should avoid any hint of advertising
>hype. Comparisons with competitors' products should be avoided
>completely.
>
>Finally, as a general rule, if you are unsure about the
>appropriateness of your posting, before you post anything please send
>a copy of what you propose to post to the BIOSCI adminstrator at
>biosci-help@net.bio.net for review.
>
>BIOSCI will takes steps to terminate network access to any reader who
>willfully violates our commercial use policies.
>
>
> 



Dr Kevin O'Donnell		     
Diagnostics and Molecular Biology
Scottish Agricultural Science Agency    
Edinburgh                         		odonnell@sasa.gov.uk          
      















From owner-diagnostics@net.bio.net Tue Aug 08 23:00:00 1995
Path: biosci!bcm!news.msfc.nasa.gov!newsfeed.internetmci.com!news.sprintlink.net!news.dgsys.com!kpl
From: Mblank@kpl.com (Martin Blankfard)
Newsgroups: bionet.diagnostics
Subject: Re: conjugate stability
Date: 7 Aug 1995 15:23:36 GMT
Organization: KPL
Lines: 72
Distribution: world
Message-ID: <405ccf$q5k_001@dgs.dgsys.com>
References: <9507028073.AA807368724@mail.fws.gov>
NNTP-Posting-Host: kpl.com
X-Newsreader: News Xpress Version 1.0 Beta #4

In article <9507028073.AA807368724@mail.fws.gov>,
   Mail-9DE~SMTP@MAIL.FWS.GOV wrote:
>
>User coler is not defined
>
>Received: from net.bio.net by mail.fws.gov (SMTPLINK V2.10.03)
>X-Envelope-From: BIOSCI-REQUEST@net.bio.net
>Received: (from daemon@localhost) by net.bio.net (8.6.12/8.6.6) id
>EAA29200 for diagnost-list; Wed, 2 Aug 1995 04:29:59 -0700
>Received: (from news@localhost) by net.bio.net (8.6.12/8.6.6) id
>EAA29192 for diagnost-arpanet; Wed, 2 Aug 1995 04:29:56 -0700
>To: diagnost@net.bio.net
>From: burns@sasa.gov.uk (Robert Burns)
>Subject: storage of conjugates
>Date: 2 Aug 1995 04:29:45 -0700
>Sender: daemon@net.bio.net
>Message-ID:
><MAPI.Id.0016.0075726e732020203632353330303030@MAPI.to.RFC822>
>NNTP-Posting-Host: net.bio.net
>
>We routinely make monoclonal AP conjugates by thiolation of the
>antibody followed by reaction with activated AP. We find that thge
>storage conditions for each conjugate is dependent on the Mab used.
>
>Some conjugates store well at 4C, some don't. All of them store well
>at -20C. We have also been looking at a Pierce product called 
>superfreeze which allows liquid storage of conjugates at -20C which
>should increase longevity. We find that some conjugates store better
>with it and some without. BTW in some cases conjugates stored with
>superfreeze had decreased activity compared to aliquots of the same
>batch stored at 4C without it!
>
>I think with Mab conjugates it all depends on the parent antibody.
>
>
>Anybody else got any conjugate stories?
>
>
>Robert
>
>
>
>Robert Burns
>
>Monoclonal Antibody Unit
>Scottish Agricultural Science Agency
>East Craigs
>Edinburgh
>Scotland
>
>burns@sasa.gov.uk
>


Most conjugates can be made stable at 4C with 50% Glycerol in Picopure water. 
This works for both poly and monoclonal conjugates with a variety of enzymes 
as long as the protein concentration is at or above 1mg/ml.  Another 
reasonable stabilizer is 1% fish gelatin.  Fat oxidation and free radicals can 
be important when obtaining fish gelatin.

Martin Blankfard
Senior Scientist
Kirkegaard and Perry Laboratories
2 Cessna Ct. 
Gaithersburg Md , 20879
Phone: (US) 1-800-638-3167 x141
FAX : 301 948 9442
E-mail: Mblank@kpl.com
08/07/95
11:41:57

 

From owner-diagnostics@net.bio.net Wed Aug 09 23:00:00 1995
Path: biosci!BEPC2.IHEP.AC.CN!wangyq
From: wangyq@BEPC2.IHEP.AC.CN
Newsgroups: bionet.diagnostics
Subject: HCG
Date: 10 Aug 1995 06:56:19 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 9
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <00994AF4.34BB5BE0.40@bepc2.ihep.ac.cn>
NNTP-Posting-Host: net.bio.net


Dear netter:

I want to buy large quantity of Bata-HCG ascites for immunodiagnosis.
It must have no cross-reaction with LH, FSH and TSH. Any information
would be very appreciated. Thank you.

Wang Yuquan
Beijing Cons Bio-Tech

From owner-diagnostics@net.bio.net Thu Aug 10 23:00:00 1995
Path: biosci!KISTMAIL.KIST.RE.KR!hyunpark
From: hyunpark@KISTMAIL.KIST.RE.KR (Park Hyun)
Newsgroups: bionet.diagnostics
Subject: (none)
Date: 11 Aug 1995 01:18:07 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9508110815.AA19766@kistmail.kist.re.kr>
NNTP-Posting-Host: net.bio.net

unsubscribe list

From owner-diagnostics@net.bio.net Thu Aug 10 23:00:00 1995
Path: biosci!rutgers!gatech!newsfeed.internetmci.com!nntp-hub2.barrnet.net!news.Stanford.EDU!not-for-mail
From: adhar@leland.Stanford.EDU (Adam Noel Harris)
Newsgroups: bionet.diagnostics,bionet.drosophila
Subject: Re: Hello, talk to me
Followup-To: bionet.diagnostics,bionet.drosophila
Date: 11 Aug 1995 10:45:15 -0700
Organization: Stanford University
Lines: 7
Message-ID: <40g4vb$s4n@elaine46.Stanford.EDU>
References: <094424Z11081995@anon.penet.fi>
NNTP-Posting-Host: elaine46.stanford.edu
X-Newsreader: TIN [version 1.2 PL2]
Xref: biosci bionet.diagnostics:247 bionet.drosophila:1290

Remember to send your complaints to admin@anon.penet.fi

Just a friendly reminder.

-Adam
 
PGP Fingerprint = C0 65 A2 BD 8A 67 B3 19  F9 8B C1 4C 8E F2 EA 0E

From owner-diagnostics@net.bio.net Thu Aug 10 23:00:00 1995
Path: biosci!rutgers!gatech!newsfeed.internetmci.com!news.sprintlink.net!in2.uu.net!panix!not-for-mail
From: reinitz@panix.com (John Reinitz)
Newsgroups: bionet.diagnostics,bionet.drosophila
Subject: Re: Hello, talk to me
Date: 11 Aug 1995 17:20:51 -0400
Organization: Panix
Lines: 25
Message-ID: <40ghjj$c4a@panix2.panix.com>
References: <094424Z11081995@anon.penet.fi>
NNTP-Posting-Host: panix2.panix.com
Xref: biosci bionet.diagnostics:248 bionet.drosophila:1294

I sent the following to admin@anon.penet.fi about the chain letter
spam, along with a copy. an350917@anon.penet.fi will now lose
access to the anon server.

Julf,

Sorry to bother you, but an350917@anon.penet.fi is spamming USENET
with the following post to bionet.drosophila and bionet.diagnostics.

This is a clear abuse. Chain letters are illegal in the United States,
and probably in most other places as well.


>----------------------------------------------------------------------------
>To find out more about the anon service, send mail to help@anon.penet.fi.
>If you reply to this message, your message WILL be *automatically* anonymized
>and you are allocated an anon id. Read the help file to prevent this.
>Please report any problems, inappropriate use etc. to admin@anon.penet.fi.

--
John Reinitz <reinitz@kruppel.molbio.mssm.edu> v:212-241-1952 f:212-860-9279
USnail: Brookdale Center for Molecular Bio., Box 1126 Mt. Sinai Med. School, 
One Gustave L. Levy Place, NYC, NY 10029 USA. I don't speak for/from Mt. Sinai.
"Absolute secrecy corrupts absolutely"--current CIA inspector-general.


From owner-diagnostics@net.bio.net Fri Aug 11 23:00:00 1995
Path: biosci!KISTMAIL.KIST.RE.KR!hyunpark
From: hyunpark@KISTMAIL.KIST.RE.KR (Park Hyun)
Newsgroups: bionet.diagnostics
Subject: diagnost@net.bio.net
Date: 11 Aug 1995 17:53:29 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9508120050.AA24180@kistmail.kist.re.kr>
NNTP-Posting-Host: net.bio.net

unsubscribe list

From owner-diagnostics@net.bio.net Mon Aug 14 23:00:00 1995
Path: biosci!SIAL.COM!patersot
From: patersot@SIAL.COM (Tom Paterson)
Newsgroups: bionet.diagnostics
Subject: subscribe
Date: 15 Aug 1995 14:09:17 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 2
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <Pine.BSI.3.91.950815152057.7162D-100000@mailgate.sial.com>
NNTP-Posting-Host: net.bio.net

subscribe diagnost


From owner-diagnostics@net.bio.net Tue Aug 15 23:00:00 1995
Path: biosci!bcm!cs.utexas.edu!geraldo.cc.utexas.edu!usenet
From: "Greg W. Peterson" <gwpeterson@mail.utexas.edu>
Newsgroups: bionet.diagnostics
Subject: Re: diagnost@net.bio.net
Date: 16 Aug 1995 17:12:01 GMT
Organization: The University of Texas at Austin
Lines: 3
Message-ID: <40t8t1$c0@geraldo.cc.utexas.edu>
References: <9508120050.AA24180@kistmail.kist.re.kr>
NNTP-Posting-Host: smf-b15.facsmf.utexas.edu
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Macintosh; I; 68K)
To: hyunpark@KISTMAIL.KIST.RE.KR
X-URL: news:9508120050.AA24180@kistmail.kist.re.kr

subscribe: bionet.diagnostics



From owner-diagnostics@net.bio.net Wed Aug 16 23:00:00 1995
Path: biosci!INDIRECT.COM!coburn
From: coburn@INDIRECT.COM (Anne Coburn)
Newsgroups: bionet.diagnostics
Subject: gopher://ftp.bio.indiana.edu:70/00/Network-News/bionet/diagnostics/Apr95.news
Date: 17 Aug 1995 05:55:42 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 117
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199508171253.FAA28990@bud.indirect.com>
NNTP-Posting-Host: net.bio.net


Hello,

I hope that this posting isn't inappropriate. I'm sure I read that job 
postings were OK. I'm a headhunter and I currently have two retained 
searchs for which scientist's in this news group might be interested. 

Both of these are IMMEDIATE openings in an independent business unit 
for a company, located in the SF Bay Area, that is known worldwide for 
quality and support. The BIOSCIENCE PRODUCTS GROUP, is dedicated to the 
development of molecular recognition, with the initial focus being a 
product for DNA recognition using microscopic arrays of fluorescently 
tagged probes. These positions offer a unique chance to work in a 
largely entrepreneurial environment, while still enjoying the benefits 
of working for a large and stable company.                


                MANAGER - DIAGNOSTICS PRODUCT DEVELOPOMENT

OBJECTIVES
- Provide the experience, maturity and focus necessary to successfully
  guide this newly formed applied research/applied development group
  composed of both Ph.D.'s and engineers.

- Serve as the primary interface between various functions within the
  BioScience Group, as well as between this business unit and central
  research, corporate management, and areas relevant to, but not in, 
  this area.

- Facilitate the timely development of a significant first product by
  using prior experience to take "interesting science" from R&D, through
  product development to commercialization.

REQUIREMENTS
- Ph.D. in Molecular Biology or closely related area. Established
  contacts with academic leaders and prinicple innovators would be
  attractive.

- 7+ years of industrial experinece (MUST HAVE!), with significant 
  emphasis on NUCLEIC ACID and DIAGNOSTIC PRODUCT DEVELOPMENT, some 
  from new technologies. Some exposure to technology evaluation and 
  acquisition would be an asset.

- Management experience of at least one group of applied R&D scientist's.
  An applicant who has started, staffed, and managed a new group will
  have a special attraction.

- Technical expertise in nucleic acids supported by an in-depth under-
  standing of the dignostics marketplace; some background involving an
  instrument as part of a product previouslyh developed; knowledge of
  manufacturing of chemistry based consumables, and a familiarity with
  the processes for both FDA approval and clinical trials.

- Flexibility, strong organizational and administrative skills, and an
  enthusiasm for team work AND hard work.

                                  
            PRODUCT MARKETING MANAGER - In Vitro DIAGNOSTICS

REQUIREMENTS
- BS in a biological or biochemical science.
- 5+ years of relevant experience in the biomedical and diagnostic
  industry.
- Familiarity with current clinical diagnostic applications and trends.
- Understanding of market drivers and market segmentations in the IVD
  market.
- Demonstrated knowledge of market drivers and market segmentations of
- the IVD market.
- Direct experience in selling, supporting or marketing successful 
  product systems to the IVD market.
- Demonstrated and applied customer-focused market research tools for 
  the development of new product systems in the market.
- Ability to perform competitive analysis on both product features and
  benefits and the related positioning of product systems in the market.
- Effective communication skills
- Knowledge of medical device regulations.
- MUST be a team player and able to work independently with minimum
  supervision.


PRODUCT MARKETING MANAGER - In Vitro 

OBJECTIVES;
- Originate and execute market research and marketing programs.
- Identify and characterize market opportunities.
- Recommend a comprehensive strategy for market entry and development 
in the IVD area.
- Identify and develop specific product opportunities and define
  strategic direction for biomolecular measurements in diagnostics.
- Work closely with R&D to formulate strategies.

REQUIREMENTS
- BS in a biological or biochemical science.
- 5+ years' relevant experience in the biomedical or diagnostic industry.
- Familiarity with current clinical diagnostic applications and trends.
- Understanding of diagnostic customer needs, applications and market 
trends.
- Demonstrated knowledge of market drivers and market segmentations 
in the IVD market.
- Direct experience in selling, supporting, or marketing successful 
product systems to the IVD markets.



For immediate, and CONFIDENTIAL consideration, contact:

ANNE COBURN
Coburn Scientific Search
4449 East Whitman
Tucson, AZ  85711-3515
Ph: 881.0084
Fax: 520.321.1475
e-mail: coburn@indirect.com





From owner-diagnostics@net.bio.net Wed Aug 16 23:00:00 1995
Path: biosci!INDIRECT.COM!coburn
From: coburn@INDIRECT.COM (Anne Coburn)
Newsgroups: bionet.diagnostics
Subject: gopher://ftp.bio.indiana.edu:70/00/Network-News/bionet/diagnostics/Apr95.news
Date: 17 Aug 1995 05:55:47 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 117
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199508171253.FAA29001@bud.indirect.com>
NNTP-Posting-Host: net.bio.net


Hello,

I hope that this posting isn't inappropriate. I'm sure I read that job 
postings were OK. I'm a headhunter and I currently have two retained 
searchs for which scientist's in this news group might be interested. 

Both of these are IMMEDIATE openings in an independent business unit 
for a company, located in the SF Bay Area, that is known worldwide for 
quality and support. The BIOSCIENCE PRODUCTS GROUP, is dedicated to the 
development of molecular recognition, with the initial focus being a 
product for DNA recognition using microscopic arrays of fluorescently 
tagged probes. These positions offer a unique chance to work in a 
largely entrepreneurial environment, while still enjoying the benefits 
of working for a large and stable company.                


                MANAGER - DIAGNOSTICS PRODUCT DEVELOPOMENT

OBJECTIVES
- Provide the experience, maturity and focus necessary to successfully
  guide this newly formed applied research/applied development group
  composed of both Ph.D.'s and engineers.

- Serve as the primary interface between various functions within the
  BioScience Group, as well as between this business unit and central
  research, corporate management, and areas relevant to, but not in, 
  this area.

- Facilitate the timely development of a significant first product by
  using prior experience to take "interesting science" from R&D, through
  product development to commercialization.

REQUIREMENTS
- Ph.D. in Molecular Biology or closely related area. Established
  contacts with academic leaders and prinicple innovators would be
  attractive.

- 7+ years of industrial experinece (MUST HAVE!), with significant 
  emphasis on NUCLEIC ACID and DIAGNOSTIC PRODUCT DEVELOPMENT, some 
  from new technologies. Some exposure to technology evaluation and 
  acquisition would be an asset.

- Management experience of at least one group of applied R&D scientist's.
  An applicant who has started, staffed, and managed a new group will
  have a special attraction.

- Technical expertise in nucleic acids supported by an in-depth under-
  standing of the dignostics marketplace; some background involving an
  instrument as part of a product previouslyh developed; knowledge of
  manufacturing of chemistry based consumables, and a familiarity with
  the processes for both FDA approval and clinical trials.

- Flexibility, strong organizational and administrative skills, and an
  enthusiasm for team work AND hard work.

                                  
            PRODUCT MARKETING MANAGER - In Vitro DIAGNOSTICS

REQUIREMENTS
- BS in a biological or biochemical science.
- 5+ years of relevant experience in the biomedical and diagnostic
  industry.
- Familiarity with current clinical diagnostic applications and trends.
- Understanding of market drivers and market segmentations in the IVD
  market.
- Demonstrated knowledge of market drivers and market segmentations of
- the IVD market.
- Direct experience in selling, supporting or marketing successful 
  product systems to the IVD market.
- Demonstrated and applied customer-focused market research tools for 
  the development of new product systems in the market.
- Ability to perform competitive analysis on both product features and
  benefits and the related positioning of product systems in the market.
- Effective communication skills
- Knowledge of medical device regulations.
- MUST be a team player and able to work independently with minimum
  supervision.


PRODUCT MARKETING MANAGER - In Vitro 

OBJECTIVES;
- Originate and execute market research and marketing programs.
- Identify and characterize market opportunities.
- Recommend a comprehensive strategy for market entry and development 
in the IVD area.
- Identify and develop specific product opportunities and define
  strategic direction for biomolecular measurements in diagnostics.
- Work closely with R&D to formulate strategies.

REQUIREMENTS
- BS in a biological or biochemical science.
- 5+ years' relevant experience in the biomedical or diagnostic industry.
- Familiarity with current clinical diagnostic applications and trends.
- Understanding of diagnostic customer needs, applications and market 
trends.
- Demonstrated knowledge of market drivers and market segmentations 
in the IVD market.
- Direct experience in selling, supporting, or marketing successful 
product systems to the IVD markets.



For immediate, and CONFIDENTIAL consideration, contact:

ANNE COBURN
Coburn Scientific Search
4449 East Whitman
Tucson, AZ  85711-3515
Ph: 881.0084
Fax: 520.321.1475
e-mail: coburn@indirect.com





From owner-diagnostics@net.bio.net Wed Aug 16 23:00:00 1995
Path: biosci!INDIRECT.COM!coburn
From: coburn@INDIRECT.COM (Anne Coburn)
Newsgroups: bionet.diagnostics
Subject: gopher://ftp.bio.indiana.edu:70/00/Network-News/bionet/diagnostics/Apr95.news
Date: 17 Aug 1995 05:55:42 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 117
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199508171253.FAA28979@bud.indirect.com>
NNTP-Posting-Host: net.bio.net


Hello,

I hope that this posting isn't inappropriate. I'm sure I read that job 
postings were OK. I'm a headhunter and I currently have two retained 
searchs for which scientist's in this news group might be interested. 

Both of these are IMMEDIATE openings in an independent business unit 
for a company, located in the SF Bay Area, that is known worldwide for 
quality and support. The BIOSCIENCE PRODUCTS GROUP, is dedicated to the 
development of molecular recognition, with the initial focus being a 
product for DNA recognition using microscopic arrays of fluorescently 
tagged probes. These positions offer a unique chance to work in a 
largely entrepreneurial environment, while still enjoying the benefits 
of working for a large and stable company.                


                MANAGER - DIAGNOSTICS PRODUCT DEVELOPOMENT

OBJECTIVES
- Provide the experience, maturity and focus necessary to successfully
  guide this newly formed applied research/applied development group
  composed of both Ph.D.'s and engineers.

- Serve as the primary interface between various functions within the
  BioScience Group, as well as between this business unit and central
  research, corporate management, and areas relevant to, but not in, 
  this area.

- Facilitate the timely development of a significant first product by
  using prior experience to take "interesting science" from R&D, through
  product development to commercialization.

REQUIREMENTS
- Ph.D. in Molecular Biology or closely related area. Established
  contacts with academic leaders and prinicple innovators would be
  attractive.

- 7+ years of industrial experinece (MUST HAVE!), with significant 
  emphasis on NUCLEIC ACID and DIAGNOSTIC PRODUCT DEVELOPMENT, some 
  from new technologies. Some exposure to technology evaluation and 
  acquisition would be an asset.

- Management experience of at least one group of applied R&D scientist's.
  An applicant who has started, staffed, and managed a new group will
  have a special attraction.

- Technical expertise in nucleic acids supported by an in-depth under-
  standing of the dignostics marketplace; some background involving an
  instrument as part of a product previouslyh developed; knowledge of
  manufacturing of chemistry based consumables, and a familiarity with
  the processes for both FDA approval and clinical trials.

- Flexibility, strong organizational and administrative skills, and an
  enthusiasm for team work AND hard work.

                                  
            PRODUCT MARKETING MANAGER - In Vitro DIAGNOSTICS

REQUIREMENTS
- BS in a biological or biochemical science.
- 5+ years of relevant experience in the biomedical and diagnostic
  industry.
- Familiarity with current clinical diagnostic applications and trends.
- Understanding of market drivers and market segmentations in the IVD
  market.
- Demonstrated knowledge of market drivers and market segmentations of
- the IVD market.
- Direct experience in selling, supporting or marketing successful 
  product systems to the IVD market.
- Demonstrated and applied customer-focused market research tools for 
  the development of new product systems in the market.
- Ability to perform competitive analysis on both product features and
  benefits and the related positioning of product systems in the market.
- Effective communication skills
- Knowledge of medical device regulations.
- MUST be a team player and able to work independently with minimum
  supervision.


PRODUCT MARKETING MANAGER - In Vitro 

OBJECTIVES;
- Originate and execute market research and marketing programs.
- Identify and characterize market opportunities.
- Recommend a comprehensive strategy for market entry and development 
in the IVD area.
- Identify and develop specific product opportunities and define
  strategic direction for biomolecular measurements in diagnostics.
- Work closely with R&D to formulate strategies.

REQUIREMENTS
- BS in a biological or biochemical science.
- 5+ years' relevant experience in the biomedical or diagnostic industry.
- Familiarity with current clinical diagnostic applications and trends.
- Understanding of diagnostic customer needs, applications and market 
trends.
- Demonstrated knowledge of market drivers and market segmentations 
in the IVD market.
- Direct experience in selling, supporting, or marketing successful 
product systems to the IVD markets.



For immediate, and CONFIDENTIAL consideration, contact:

ANNE COBURN
Coburn Scientific Search
4449 East Whitman
Tucson, AZ  85711-3515
Ph: 881.0084
Fax: 520.321.1475
e-mail: coburn@indirect.com





From owner-diagnostics@net.bio.net Wed Aug 16 23:00:00 1995
Path: biosci!bcm!news.msfc.nasa.gov!newsfeed.internetmci.com!news.sprintlink.net!in1.uu.net!tank.news.pipex.net!pipex!warwick!news.ncl.ac.uk!usenet
From: Simon Eaton <S.J.Eaton@ncl.ac.uk>
Newsgroups: bionet.diagnostics
Subject: Inborn Errors Mailing List
Date: 17 Aug 1995 17:03:26 GMT
Organization: Newcastle University, UK
Lines: 25
Message-ID: <40vsou$pnn@whitbeck.ncl.ac.uk>
NNTP-Posting-Host: russet.ncl.ac.uk
Mime-Version: 1.0
X-Newsreader: WinVN 0.99.4

There has been a mailing list set up for the discussion of inborn 
errors of metabolism. . We intend to set up
a newsgroup eventually but in order to gauge support, have decided to 
set up a mailbase newsgroup first.
The intention is to provide a discussion of research into Inherited 
Metabolic Diseases, which can be important causes of disease in both 
children and adults. The discussion will include: a) Biochemistry and 
Diagnosis b) Genetics c) Clinical, nutritional and treatment 
aspects d) General discussion.  

Joining inborn-errors
To join inborn-errors send the command:
Join inborn-errors firstname(s) lastname
(substituting appropriately) as the only text in the body of a 
message addressed to:
mailbase@mailbase.ac.uk
For any queries relating to the list, contact the owner at:
inborn-errors-request@mailbase.ac.uk

For general information relating to Mailbase, see 
http://www.mailbase.ac.uk/
You can get to the inborn-errors list page from this URL, or directly 
using the URL
gopher://nisp.ncl.ac.uk:70/11/lists-f-j/inborn-errors


From owner-diagnostics@net.bio.net Thu Aug 17 23:00:00 1995
Path: biosci!bcm!news.msfc.nasa.gov!europa.chnt.gtegsc.com!news.mathworks.com!newshost.marcam.com!usc!howland.reston.ans.net!tank.news.pipex.net!pipex!sunsite.doc.ic.ac.uk!daresbury!nntp-trd.UNINETT.no!nntp.uio.no!pcdnr05.uio.no!user
From: olam@radium.uio.no (Ola Myklebost)
Newsgroups: bionet.diagnostics,bit.med.mxdiag-l,sci.med.pathology
Subject: Experiences with lab standards for genetic testing?
Date: 18 Aug 1995 06:57:55 GMT
Organization: Inst for Cancer Research, Oslo
Lines: 34
Message-ID: <olam-1808950900280001@pcdnr05.uio.no>
NNTP-Posting-Host: pcdnr05.uio.no
Xref: biosci bionet.diagnostics:256 sci.med.pathology:1185

In Norway we have a new law on medical applications of biotechnology,
where there is opportunity to regulate artificial fertilization,
preimplantation diagnostics, pre- and postnatal genetic testing and gene
therapy.

We are currently discussing the criteria for allowing a lab to do genetic
tests, and for allowing specific tests.

One may require the lab to be accredited, by which their way of performing
specific procedures is quality controlled by an external body. By this
procedure they have to do tests in a specific way over long periods.

An alternative, perhaps better suited for research labs and quickly
developing procedures, one may require the lab to get a GLP (Good lab.
practise) certificate. 

In both cases an external body will irregularly visit the lab, check the
records and the way work is done.

What is the experience in other countries, have quality controls been
enforced in this way anywhere? I think some Dutch and British labs have
been certified. It would be interesting to hear from these (or be pointed
towards them).

Ola

-- 
Ola Myklebost                   Email  ola.myklebost@labmed.uio.no
Dept of Tumor Biology
Inst for Cancer Research        Tel +47-2293-4299
The Norwegian Radium Hospital   Fax +47-2252-2421
N-0310 OSLO, Norway

WWW presentation: http://www.med.uio.no/dnr/Inst/TumBiol/Ola/Ola.html

From owner-diagnostics@net.bio.net Sat Aug 19 23:00:00 1995
Newsgroups: bionet.diagnostics
Path: biosci!agate!howland.reston.ans.net!news.sprintlink.net!crash!kiehl
From: b3748@cts.com (Bryan Kiehl)
Subject: Human Mycoplasma Serology
Organization: CTSNET
Date: Sat, 19 Aug 1995 19:11:14 GMT
Message-ID: <415d0i$1s4k_001@kiehl.cts.com>
X-Newsreader: News Xpress Version 1.0 Beta #3
Sender: news@crash.cts.com (news subsystem)
Nntp-Posting-Host: kiehl.cts.com
Lines: 20

I am completing field studies of a mycoplasma pnuemonia IgM serology test, but 
would like to use the assay for prospective studies during the next few months 
while the FDA reviews our controlled study data. The test is in a mirotiter 
well format, using purified complement fixing antigen and an anti-human IgG 
absorbent.

We can pay for limited technician time and support either publication and/or 
limited transportation costs. The comparison needs to be made using at least 
10 true positive patients and 20 patients that present with pneumonia, but 
are later defined not to have M. pneumonia infection. Defininition needs to 
be by means other than serology.

If interested, please let me know.

Bryan Kiehl
GenBio
15222-A Avenue of Science
San Diego, CA 92128
(619) 592-9300, ext 309
(619) 592-9400 [FAX]

From owner-diagnostics@net.bio.net Sun Aug 20 23:00:00 1995
Path: biosci!bcm!bcm.tmc.edu!news.msfc.nasa.gov!newsfeed.internetmci.com!howland.reston.ans.net!tank.news.pipex.net!pipex!sunsite.doc.ic.ac.uk!dundee.ac.uk!usenet
From: keith appleyard <kappleyard@ninewells.dundee.ac.uk>
Newsgroups: bionet.diagnostics,bionet.drosophila
Subject: Re: Hello, talk to me
Date: 21 Aug 1995 11:55:47 GMT
Organization: Dundee University
Lines: 13
Message-ID: <419s83$bnq@dux.dundee.ac.uk>
References: <094424Z11081995@anon.penet.fi> <40ghjj$c4a@panix2.panix.com>
NNTP-Posting-Host: pub17.medschool.dundee.ac.uk
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Mailer: Mozilla 1.1N (Windows; I; 16bit)
Xref: biosci bionet.diagnostics:259 bionet.drosophila:1322

Earlier this year a research group in California was conducting research 
into "memes" on the internet. This involves tracing chain mail and 
monitoring how it changes as time progresses. If you come across any 
chainmail of this sort send them a copy at meme@scottlabsgi.chem.sfu.ca 
atthe same time that you complain and ask for it's removal.

-- 
Keith Appleyard BSc, Senior Scientific Officer, Virology
Ninewells Hospital and Medical School, Dundee DD1 9SY,
U.K, e-mail kappleyard@ninewells.dundee.ac.uk
Tel: U.K 01382 662559 Fax: U.K 01382 641907



From owner-diagnostics@net.bio.net Mon Aug 21 23:00:00 1995
Newsgroups: bionet.diagnostics
Path: biosci!daresbury!nntp-trd.UNINETT.no!sunic!sunic.sunet.se!news.sprintlink.net!in1.uu.net!newsflash.concordia.ca!nstn.ns.ca!news.cs.indiana.edu!umn.edu!news
From: "lili@ee.umn.edu... Li Li" <lili@ee.umn.edu>
Subject: Re: Problems with DNA based technology
To: NAB@LGC.CO.UK
Message-ID: <83545.lili@ee.umn.edu>
X-Minuet-Version: Minuet1.0_Beta_16
Sender: news@news.cis.umn.edu (Usenet News Administration)
Nntp-Posting-Host: dialup-3-224.gw.umn.edu
X-Popmail-Charset: English
Organization: University of Minnesota, Twin Cities
Date: Tue, 22 Aug 1995 02:24:07 GMT
Lines: 26

On 31 Jul 1995 12:11:00 +0100, 
NAB@LGC.CO.UK  <NAB@LGC.CO.UK> wrote:

>I am conducting a survey to identify the suitability and
>limitations of key DNA based technologies. These include nucleic
>acid extraction methods: yield, purity of product, carryover of
>chemicals which could inhibit subsequent PCR, one tube protocols
>etc. Hybridisation protocols, non-radioactive labelling methods:
>relative sensitivity and probe stability etc. I am also
>interested in problems associated with all forms of PCR
>especially RT-PCR and forensic techniques such as RFLP and STR
>profiling, CAP, AFLP etc. Any problems you have experienced and
>any suggestions would be more than welcome. I,ve got until the 30
>September 1995 so HELP!
>
>
I read your message.  It is interesting.  I have an engineering background
and I am thinking doing some research on biomedical engineering.  The 
initial step is scaling down the DNA sequencing by micromachined 
electronical technology.  Since this is just start.  I hope you can 
exchange some ideas with me.
Li Li
Dept. of electrical engineering
University of Minnesota



From owner-diagnostics@net.bio.net Mon Aug 21 23:00:00 1995
Path: biosci!MENZIES.SU.EDU.AU!antje
From: antje@MENZIES.SU.EDU.AU (Antje Haase)
Newsgroups: bionet.diagnostics
Subject: PCR of blood
Date: 22 Aug 1995 00:15:03 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 21
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9508220720.AA06715@menzies.su.edu.au>
NNTP-Posting-Host: net.bio.net

Hi everybody,

we are trying to detect small numbers of bacteria in blood samples. After
having tried a number of methods described in the literature we are not quite
happy with the sensitivity. The number of bacteria is far too small to just
spin them put and DNA extraction doesn't feel like the way to go either for
the same reason. We have tried various membraneswithout success. 

Does anyone have experience with this problem? Any help or suggestions are
greatly appreciated

thanks in advance

Antje

__________________________________________
Antje Haase
Menzies School of  Health Research
Australia
email: antje@menzies.su.edu.au
__________________________________________

From owner-diagnostics@net.bio.net Mon Aug 21 23:00:00 1995
Path: biosci!NFRSSJ.AGR.CA!HAMPSONM
From: HAMPSONM@NFRSSJ.AGR.CA
Newsgroups: bionet.diagnostics
Subject: viability staining
Date: 22 Aug 1995 05:07:26 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 14
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01HUD7BMT9F6000EPR@GW.AGR.CA>
NNTP-Posting-Host: net.bio.net

Hello Netters,
I work with the chytridiomycete Synchytrium endobioticum.
The overwintering body is a resting spore.  This is an
obligate (to potato) fungus and reproduces in potato
tissue cells.  It does not produce a mycelium.  It is
difficult to tell from light microscopy if the spore
is viable or not.  Population viability can be estimated
somewhat in bioassay with potatoes, but I need a method
to identify single spore viability.  I have tried many
flurochromes - settling on acriflavin - but it is not
a surefire system.  There is not much that I can find in
the literature to help me.  Are there some new products
out there that I can try?  Any suggestion will be much
appreciated. Thanks. Mike Hampson (hampsonm@NFRSSJ.agr.ca).

From owner-diagnostics@net.bio.net Tue Aug 22 23:00:00 1995
Path: biosci!EM.AGR.CA!BrescianiS
From: BrescianiS@EM.AGR.CA (Sandy Bresciani)
Newsgroups: bionet.diagnostics
Subject: diagnostic kits for mycotoxin analysis
Date: 23 Aug 1995 10:22:10 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 19
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <s03b2ae5.005@EM.AGR.CA>
NNTP-Posting-Host: net.bio.net

To list members:

I am looking for the names  of companies that produce/market/sell
diagnostic kits for the testing of mycotoxins in grains, feed, or food
products.  I am trying to compile a complete "global" list of such
companies.  I was wondering if anyone could provide the names of
companies involved in this industry as well as any relevant information
regarding the company such as country of origin, e-mail address, phone
number, etc.  Any  information would be useful even if it is just the name of
a company. 

Thanks,

Sandy Bresciani
brescianis@em.agr.ca
Agriculture and Agri-Food Canada
tel: 306-975-6421
fax: 306-975-6419


From owner-diagnostics@net.bio.net Tue Aug 22 23:00:00 1995
Path: biosci!daresbury!not-for-mail
From: Sandy Bresciani <BrescianiS@EM.AGR.CA>
Newsgroups: bionet.diagnostics
Subject: diagnostic kits for analysing mycotoxins
Date: 23 Aug 1995 18:55:09 +0100
Lines: 19
Sender: lpddist@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <41fq1t$oii@mserv1.dl.ac.uk>
Original-To: diagnost@dl.ac.uk

To list members:

I am looking for the names  of companies that produce/market/sell
diagnostic kits for the testing of mycotoxins in grains, feed, or food
products.  I am trying to compile a complete "global" list of such
companies.  I was wondering if anyone could provide the names of
companies involved in this industry as well as any relevant information
regarding the company such as country of origin, e-mail address, phone
number, etc.  Any  information would be useful even if it is just the name of
a company. 

Thanks,

Sandy Bresciani
brescianis@em.agr.ca
Agriculture and Agri-Food Canada
tel: 306-975-6421
fax: 306-975-6419


From owner-diagnostics@net.bio.net Thu Aug 24 23:00:00 1995
Path: biosci!TECHNET.SG!pohyam
From: pohyam@TECHNET.SG (Lim Pohyam)
Newsgroups: bionet.diagnostics
Subject: sample addition indicators
Date: 25 Aug 1995 08:22:21 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 5
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199508251520.XAA25193@einstein.technet.sg>
NNTP-Posting-Host: net.bio.net

I have tried to make IgM ELIsa for syphilis. One problem I encountered was I 
forget to add in the samples after several hundred tests. Anyone tried to 
add in colour dyes to eliminate this error? Or are there dyes that are 
sensitive to pH changes upon addition of sera? Any help would be appreciated.


From owner-diagnostics@net.bio.net Thu Aug 24 23:00:00 1995
Path: biosci!agresearch.cri.nz!HartA
From: HartA@agresearch.cri.nz
Newsgroups: bionet.diagnostics
Subject: Drying retardants
Date: 24 Aug 1995 21:49:51 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 9
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <01HUHWMY0YWY004WCP@INVERMAY.CRI.NZ>
NNTP-Posting-Host: net.bio.net


Suppose I have a thin aqueous film containing enzyme(s). Can anyone suggest 
a suitable additive(s) which will prevent the film from drying out, without 
affecting the activity of the enzyme?

Thanks,

Alan Hart,
AgResearch Grasslands.

From owner-diagnostics@net.bio.net Thu Aug 24 23:00:00 1995
Path: biosci!daresbury!nntp-trd.UNINETT.no!Norway.EU.net!EU.net!gatech!newsfeed.pitt.edu!dsinc!netnews.upenn.edu!cronkite.ocis.temple.edu!astro.ocis.temple.edu!gold
From: gold@astro.ocis.temple.edu (Bert Gold)
Newsgroups: bionet.diagnostics
Subject: Experiences with lab standards for genetic testing?
Date: 25 Aug 1995 21:31:35 GMT
Organization: Temple University, Academic Computer Services
Lines: 27
Message-ID: <41lffn$ect@cronkite.ocis.temple.edu>
NNTP-Posting-Host: astro.ocis.temple.edu
X-Newsreader: TIN [version 1.2 PL2]

There has been a good deal of experience in the U.S. with this since
the implementation of CLIA (The Clinical Laboratory Improvement Act
of 1988) in around 1991-92 and with the beginning of Board Certification
in Human Molecular Genetics in 1990 and the subsequent exam in 1993.

I, myself, served on an inspection team for the College of American
Pathologists (in Chicago, which effectively operates as an oversight
body through CLIA), in a well-known lab. in Boston.  They passed with
flying colors, though the insepection was rigorous.

One of the reasons I am leaving my current job is that neither my
department chairman nor Dean of the Medical School will provide sufficient
resources to allow me to pass such a rigorous inspection.

Therefore, I'm off to UCSF to become board certified...

If you have more questions about the rigors of being a well certified lab,
please feel free to call or EMAIL.

Yours,

Bert Gold, Ph.D.
Director, Molecular Pathology Laboratory, Temple U.
and (hopefully) Board Eligible
Human Molecular Geneticist

 

From owner-diagnostics@net.bio.net Fri Aug 25 23:00:00 1995
Path: biosci!agate!howland.reston.ans.net!newsfeed.internetmci.com!usenet.eel.ufl.edu!freenet3.freenet.ufl.edu!afn26055
From: "Edward R. Mason" <afn26055@freenet.ufl.edu>
Newsgroups: bionet.diagnostics
Subject: Re: diagnostic kits for analysing mycotoxins
Date: Sat, 26 Aug 1995 10:17:41 -0400
Lines: 35
Message-ID: <Pine.A32.3.91.950826101207.28889A-100000@freenet3.freenet.ufl.edu>
References: <41fq1t$oii@mserv1.dl.ac.uk>
NNTP-Posting-Host: freenet3.afn.org
Mime-Version: 1.0
Content-Type: TEXT/PLAIN; charset=US-ASCII
In-Reply-To: <41fq1t$oii@mserv1.dl.ac.uk> 

Sandy,
One such company would be:
ELISA Technologies
phone 904-462-4546
fax   904-462-3453
One Progress Blvd., Suite #28
Alachua, FL   32615
Bruce Ritter or Eugene Fueyo can probably help.

Best regards,
Edward Mason

On 23 Aug 1995, Sandy Bresciani wrote:

> To list members:
> 
> I am looking for the names  of companies that produce/market/sell
> diagnostic kits for the testing of mycotoxins in grains, feed, or food
> products.  I am trying to compile a complete "global" list of such
> companies.  I was wondering if anyone could provide the names of
> companies involved in this industry as well as any relevant information
> regarding the company such as country of origin, e-mail address, phone
> number, etc.  Any  information would be useful even if it is just the name of
> a company. 
> 
> Thanks,
> 
> Sandy Bresciani
> brescianis@em.agr.ca
> Agriculture and Agri-Food Canada
> tel: 306-975-6421
> fax: 306-975-6419
> 
> 
> 

From owner-diagnostics@net.bio.net Sun Aug 27 23:00:00 1995
Path: biosci!idbiomed.com!FouziB
From: FouziB@idbiomed.com (Fouzi Bekkaoui)
Newsgroups: bionet.diagnostics
Subject: Subscribe
Date: 28 Aug 1995 14:00:51 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <30422DD7@mailbox.electric.net>
NNTP-Posting-Host: net.bio.net



From owner-diagnostics@net.bio.net Mon Aug 28 23:00:00 1995
Path: biosci!sasa.gov.uk!burns
From: burns@sasa.gov.uk (Robert Burns)
Newsgroups: bionet.diagnostics
Subject: test please ignore
Date: 29 Aug 1995 06:19:23 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 12
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.0075726e732020203135464630303031@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net


Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Mon Aug 28 23:00:00 1995
Path: biosci!sasa.gov.uk!burns
From: burns@sasa.gov.uk (Robert Burns)
Newsgroups: bionet.diagnostics
Subject: enzyme kinetics in ELISA
Date: 29 Aug 1995 02:11:52 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 28
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.0075726e732020204444363930303031@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

Message from Isla Browning via Robert Burns( my E mail is out of order)

My son is writing up a school project in which he carried out 
experiments to calculate the Km of alkaline phosphatase acting on 
p-nitrophenylphosphate in both ELISA, and when the enzyme is free in 
solution. The experiments were carried out at 25C and at a pH of 9.8. 
The result was Km= 0.246 for the immobilised enzyme and 0.505 for the 
free solution. I would be grateful for any comments on these results. 
It means that there was greater affinity of the enzyme for the 
substrate when it was immobilised, which is not what we expected.

Isla Browning
Diagnostics and Molecular Biology Section
SASA
Edinburgh
Tel 0131 244 8916

Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Mon Aug 28 23:00:00 1995
Path: biosci!aol.com!PandaGroup
From: PandaGroup@aol.com
Newsgroups: bionet.diagnostics
Subject: TECHSCAN (sm) Services
Date: 28 Aug 1995 20:27:38 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 51
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <950828232455_85823571@mail02.mail.aol.com>
NNTP-Posting-Host: net.bio.net


TECHSCAN (sm) SERVICES OFFERED WORLDWIDE

The Panda Group, Inc. announces the availability of its TECHSCAN 
(sm) services for companies in the biomedical and biotechnology 
industries, including diagnostics, pharmaceuticals, 
biopharmaceuticals, biologicals, etc.

TECHSCAN (sm) is a technology assessment service by which 
participants in international biomedical and biotechnology 
industries can keep abreast of the latest technology developments 
arising in the United States and Canada.  Our consultants will 
survey the scientific, technical, and industrial literature 
concerning your interests.  They will then assess the scientific 
and commercial potential of each finding, and report to you on 
the key progress in your areas of interest, along with summaries 
and comments on each item.

TECHSCAN (sm) is a convenient and efficient means of monitoring 
technological advances made in research centers, hospitals, 
universities, and by competitors.  Unlike literature searches, 
TECHSCAN (sm) provides you with only prescreened information 
based on your search criteria and the technical expertise of our 
consultants, and cogent commentary on each entry.  It can provide 
the basis for the acquisition and licensing of new technology 
developed in North America.

TECHSCAN (sm) is also a proprietary service.  That is, The Panda 
Group, Inc. will not perform searches and assessments of the same 
technology for companies in direct competition in the same 
markets.  You can, therefore, be assured that the information you 
pay for will provide you with a market edge over your 
competition.  In addition, TECHSCAN (sm) subscribers have access 
to the complete consulting capabilities of The Panda Group, Inc. 
for further investigation of selected technologies and initiation 
of licensing/acquisition contacts in the United States and 
Canada.  TECHSCAN (sm) can provide companies outside of North 
America with an important source of technological intelligence 
and opportunity.

For further information, e-mail us at PandaGroup@aol.com or 
phone/fax our offices at 1-619-436-4341.

=====================

Founded in 1983, The Panda group, Inc. is a Southern California-
based, internationally recognized consulting firm specializing in 
the biomedical and biotechnology industries.  It's client list 
includes many well-know multinational corporations as well as 
smaller biomedical and biotechnology companies.


From owner-diagnostics@net.bio.net Mon Aug 28 23:00:00 1995
Path: biosci!IX.NETCOM.COM!borschel
From: borschel@IX.NETCOM.COM (Richard Borschel)
Newsgroups: bionet.diagnostics
Subject: Searching for Lamin A,B,C
Date: 29 Aug 1995 10:10:21 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 10
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <199508291631.JAA27291@ix4.ix.netcom.com>
NNTP-Posting-Host: net.bio.net

I am looking for help in finding purified Lamin A, B, and C and any 
Mab's specific for them.  I appreciate any help I can get on this as I 
would like to avoid purifying them myself.
-- 
Major Richard Borschel                    	  E-mail: borschel@ix.netcom.com
Chief, Research Operstions Service
Department of Clinical Investigation       
Walter Reed Army Medical Center      			Phone: (202) 782-0120
Washington, DC 20307                         		FAX: (202) 782-3286


From owner-diagnostics@net.bio.net Tue Aug 29 23:00:00 1995
Path: biosci!MAIL.FWS.GOV!Mail-9DE~SMTP
From: Mail-9DE~SMTP@MAIL.FWS.GOV
Newsgroups: bionet.diagnostics
Subject: enzyme kinetics
Date: 30 Aug 1995 02:08:50 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 46
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <9507298097.AA809717152@mail.fws.gov>
NNTP-Posting-Host: net.bio.net



Message from Isla Browning via Robert Burns( my E mail is out of
order)

My son is writing up a school project in which he carried out 
experiments to calculate the Km of alkaline phosphatase acting on 
p-nitrophenylphosphate in both ELISA, and when the enzyme is free in 
solution. The experiments were carried out at 25C and at a pH of 9.8. 
The result was Km= 0.246 for the immobilised enzyme and 0.505 for the 
free solution. I would be grateful for any comments on these results. 
It means that there was greater affinity of the enzyme for the 
substrate when it was immobilised, which is not what we expected.

Isla Browning
Diagnostics and Molecular Biology Section
SASA
Edinburgh
Tel 0131 244 8916

Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk






Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



From owner-diagnostics@net.bio.net Tue Aug 29 23:00:00 1995
Path: biosci!sasa.gov.uk!browning
From: browning@sasa.gov.uk (Isla Browning)
Newsgroups: bionet.diagnostics
Subject: Enzyme kinetics in ELISA
Date: 30 Aug 1995 06:55:55 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 16
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.00726f776e696e673546394330303031@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net

My son is writing up a school project in which he carried out 
experiments to calculate the Km of alkaline phosphatase acting on p- 
nitrophenylphosphate in both ELISA and when the enzyme is free in 
solution.The experiments were carried out at 25C and at a pH of 
9.8.The result was Km= 0.246 for the immobilised enzyme and 0.505 
for the free solution. I would be grateful for any comments on these 
results. It means that there was greater affinity of the enzyme for the 
substrate when it was immobilised, which is not what we expected.

Isla Browning
Diagnostics and Molecular Biology Section
SASA
Edinburgh
Tel



From owner-diagnostics@net.bio.net Thu Aug 31 23:00:00 1995
Path: biosci!sasa.gov.uk!burns
From: burns@sasa.gov.uk (Robert Burns)
Newsgroups: bionet.diagnostics
Subject: test ignore
Date: 1 Sep 1995 09:23:18 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 12
Sender: daemon@net.bio.net
Distribution: world
Message-ID: <MAPI.Id.0016.0075726e732020203335354130303132@MAPI.to.RFC822>
NNTP-Posting-Host: net.bio.net


Robert Burns

Monoclonal Antibody Unit
Scottish Agricultural Science Agency
East Craigs
Edinburgh
Scotland

burns@sasa.gov.uk



